e-learning
resources
Berlin 2008
Saturday, 04.10.2008
PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Debate: Antibiotic treatment is contraindicated in acute bronchitis - PRO
T. Verheij (Utrecht, Netherlands)
Source:
Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis
Session:
PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis
Session type:
Postgraduate Course
Number:
64
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Verheij (Utrecht, Netherlands). Debate: Antibiotic treatment is contraindicated in acute bronchitis - PRO. Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Debate: Antibiotic treatment is contraindicated in acute bronchitis - CON
Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis
Year: 2008
Debate: Bacteria are a cause of acute bronchitis - PRO
Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis
Year: 2008
Antibiotic prescribing in patients with acute bronchitis
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007
Is there a place for oral mucolytics in the prevention of LRTI? - PRO
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009
Late Breaking Abstract - Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid - Data from 38,820 outpatients.
Source: International Congress 2019 – Comorbidities galore in respiratory patients
Year: 2019
Debate: Bacteria are a cause of acute bronchitis - CON
Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis
Year: 2008
Antibiotic prescribing in acute respiratory infections – are we following guidelines?
Source: Eur Respir J 2006; 28: Suppl. 50, 349s
Year: 2006
Inhaled antibiotics in ventilator-associated pneumonia: treatment or prophylaxis?
Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Year: 2016
Antibiotic treatment strategies in adults with bronchiectasis
Source: Eur Respir Mon 2011; 52: 211-222
Year: 2011
Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: Fact or fiction?
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013
Duration of inhaled corticosteroid therapy in children with asthma and frequency of community-acquired pneumonia in them
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016
Antibiotic treatment and prophylaxis
Source: Annual Congress 2006 - Infections and chronic obstructive lung diseases
Year: 2006
Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment?
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Late Breaking Abstract - Effect of adjunctive tobramycin inhalation therapy in the treatment of ventilator-associated pneumonia: findings from the randomized VAPORISE trial
Source: International Congress 2019 – Recent developments in intensive care unit medicine
Year: 2019
Critical illness-related corticosteroid insufficiency and community-acquired pneumonia: back to the future!
Source: Eur Respir J 2008; 31: 1150-1152
Year: 2008
What is the role of prophylactic antibiotic therapy in chronic bronchitis or COPD?
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009
Less is more? Antibiotic treatment duration for exacerbations of bronchiectasis
Source: Eur Respir J, 58 (6) 2101416; 10.1183/13993003.01416-2021
Year: 2021
Treatment to prevent exacerbations in bronchiectasis: macrolides as first line?
Source: Eur Respir J, 54 (1) 1901213; 10.1183/13993003.01213-2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept